REGENXBIO Inc 10-Q for FY2022 Q3
REGENXBIO Inc. (RGNX)
10-Q
2022-11-03
For: 2022-09-30
View Original
Added on
April 06, 2026
About this 10-Q
REGENXBIO Inc filed this 10-Q on November 3, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $26.51M
- down 13.8% from $30.77M a year earlier
- Net loss
- $75.48M
- compared with a net loss of $58.41M a year earlier
- Diluted EPS
- -$1.75
- compared with -$1.37 a year earlier